Indian propolis ameliorates the mitomycin C-induced testicular toxicity by reducing DNA damage and elevating the antioxidant activity

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Development of excellent curative therapy for most of the malignancies has resulted in a growing population of cancer survivors who are at increased risk for a variety of health problems including infertility. Therefore, fertility preservation has become an important issue during cancer treatment in recent years. Combination therapy with natural agents such as vitamins, antioxidants, dietary supplements, and plant products are considered as an attractive option to mitigate normal tissue toxicity imparted by chemotherapy. The aim of the present study was to explore the beneficial effect of hydroethanolic extract of Indian propolis (HEIP) on mitigating mitomycin C (MMC)-induced testicular damage and its mechanism of action. Healthy adult male mice were injected intraperitoneally with saline, MMC, HEIP and HEIP followed by MMC after 1 h. The animals were dissected at 35 days after various treatments to analyze testicular function. MMC administration resulted in significant reduction in testicular function in a dose-dependent manner at 35 days after treatment which significantly improved by HEIP pre-treatment. At 24 h after treatment, MMC induced significant increase in oxidative stress, γ-H2AX foci and expression of RAD51 and KU80 in testicular cells. Prior treatment with HEIP decreased the oxidative stress, reduced DNA damage and restored the testicular testosterone and inhibin B level. In conclusion, co-administration of Indian propolis extract may play a promising beneficial role in fertility preservation of males undergoing chemotherapy.

Original languageEnglish
Pages (from-to)252-263
Number of pages12
JournalBiomedicine and Pharmacotherapy
Volume95
DOIs
Publication statusPublished - 01-11-2017

Fingerprint

Propolis
Mitomycin
DNA Damage
Antioxidants
Fertility Preservation
Therapeutics
Oxidative Stress
Drug Therapy
Neoplasms
Inhibins
Dietary Supplements
Vitamins
Infertility
Testosterone
Health

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{996c297da16841e6ba70599be134b7f3,
title = "Indian propolis ameliorates the mitomycin C-induced testicular toxicity by reducing DNA damage and elevating the antioxidant activity",
abstract = "Development of excellent curative therapy for most of the malignancies has resulted in a growing population of cancer survivors who are at increased risk for a variety of health problems including infertility. Therefore, fertility preservation has become an important issue during cancer treatment in recent years. Combination therapy with natural agents such as vitamins, antioxidants, dietary supplements, and plant products are considered as an attractive option to mitigate normal tissue toxicity imparted by chemotherapy. The aim of the present study was to explore the beneficial effect of hydroethanolic extract of Indian propolis (HEIP) on mitigating mitomycin C (MMC)-induced testicular damage and its mechanism of action. Healthy adult male mice were injected intraperitoneally with saline, MMC, HEIP and HEIP followed by MMC after 1 h. The animals were dissected at 35 days after various treatments to analyze testicular function. MMC administration resulted in significant reduction in testicular function in a dose-dependent manner at 35 days after treatment which significantly improved by HEIP pre-treatment. At 24 h after treatment, MMC induced significant increase in oxidative stress, γ-H2AX foci and expression of RAD51 and KU80 in testicular cells. Prior treatment with HEIP decreased the oxidative stress, reduced DNA damage and restored the testicular testosterone and inhibin B level. In conclusion, co-administration of Indian propolis extract may play a promising beneficial role in fertility preservation of males undergoing chemotherapy.",
author = "Sandhya Kumari and Guruprasad Nayak and Lukose, {Sonu T.} and Kalthur, {Sneha Guruprasad} and Nandini Bhat and Hegde, {Aswathi R.} and Srinivas Mutalik and Guruprasad Kalthur and Adiga, {Satish Kumar}",
year = "2017",
month = "11",
day = "1",
doi = "10.1016/j.biopha.2017.08.065",
language = "English",
volume = "95",
pages = "252--263",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Indian propolis ameliorates the mitomycin C-induced testicular toxicity by reducing DNA damage and elevating the antioxidant activity

AU - Kumari, Sandhya

AU - Nayak, Guruprasad

AU - Lukose, Sonu T.

AU - Kalthur, Sneha Guruprasad

AU - Bhat, Nandini

AU - Hegde, Aswathi R.

AU - Mutalik, Srinivas

AU - Kalthur, Guruprasad

AU - Adiga, Satish Kumar

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Development of excellent curative therapy for most of the malignancies has resulted in a growing population of cancer survivors who are at increased risk for a variety of health problems including infertility. Therefore, fertility preservation has become an important issue during cancer treatment in recent years. Combination therapy with natural agents such as vitamins, antioxidants, dietary supplements, and plant products are considered as an attractive option to mitigate normal tissue toxicity imparted by chemotherapy. The aim of the present study was to explore the beneficial effect of hydroethanolic extract of Indian propolis (HEIP) on mitigating mitomycin C (MMC)-induced testicular damage and its mechanism of action. Healthy adult male mice were injected intraperitoneally with saline, MMC, HEIP and HEIP followed by MMC after 1 h. The animals were dissected at 35 days after various treatments to analyze testicular function. MMC administration resulted in significant reduction in testicular function in a dose-dependent manner at 35 days after treatment which significantly improved by HEIP pre-treatment. At 24 h after treatment, MMC induced significant increase in oxidative stress, γ-H2AX foci and expression of RAD51 and KU80 in testicular cells. Prior treatment with HEIP decreased the oxidative stress, reduced DNA damage and restored the testicular testosterone and inhibin B level. In conclusion, co-administration of Indian propolis extract may play a promising beneficial role in fertility preservation of males undergoing chemotherapy.

AB - Development of excellent curative therapy for most of the malignancies has resulted in a growing population of cancer survivors who are at increased risk for a variety of health problems including infertility. Therefore, fertility preservation has become an important issue during cancer treatment in recent years. Combination therapy with natural agents such as vitamins, antioxidants, dietary supplements, and plant products are considered as an attractive option to mitigate normal tissue toxicity imparted by chemotherapy. The aim of the present study was to explore the beneficial effect of hydroethanolic extract of Indian propolis (HEIP) on mitigating mitomycin C (MMC)-induced testicular damage and its mechanism of action. Healthy adult male mice were injected intraperitoneally with saline, MMC, HEIP and HEIP followed by MMC after 1 h. The animals were dissected at 35 days after various treatments to analyze testicular function. MMC administration resulted in significant reduction in testicular function in a dose-dependent manner at 35 days after treatment which significantly improved by HEIP pre-treatment. At 24 h after treatment, MMC induced significant increase in oxidative stress, γ-H2AX foci and expression of RAD51 and KU80 in testicular cells. Prior treatment with HEIP decreased the oxidative stress, reduced DNA damage and restored the testicular testosterone and inhibin B level. In conclusion, co-administration of Indian propolis extract may play a promising beneficial role in fertility preservation of males undergoing chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=85028309848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028309848&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2017.08.065

DO - 10.1016/j.biopha.2017.08.065

M3 - Article

AN - SCOPUS:85028309848

VL - 95

SP - 252

EP - 263

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

ER -